insights_auto
Why is INO down ၂.၀၅%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
၁.၄၃ US$
arrow_downward
-၂.၀၅%(-၀.၀၃၀) 1D
၁.၄၂ US$
arrow_downward
-၀.၇၀% (-၀.၀၁၀၀)todayPre-market
Closed: နို ၁၃, GMT-၅ ၁၆:၀၀:၀၁ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
၁.၄၄ US$
High
၁.၄၈ US$
Low
၁.၃၉ US$
Mkt. cap
၂၆.၇၈ ကုဋေ
Avg. vol.
၁.၉၃ ကုဋေ
Volume
၁.၇၇ သောင်း
52-wk high
၂.၇၂ US$
52-wk low
၀.၅၆ US$
EPS
-၀.၈၀ US$
Beta
၁.၇၁
Shares outstanding
၁၈.၇၃ ကုဋေ
No. of employees
၁၁၂
Open
၁.၄၄ US$
High
၁.၄၈ US$
Low
၁.၃၉ US$
Mkt. cap
၂၆.၇၈ ကုဋေ
Avg. vol.
၁.၉၃ ကုဋေ
Volume
၁.၇၇ သောင်း
52-wk high
၂.၇၂ US$
52-wk low
၀.၅၆ US$
EPS
-၀.၈၀ US$
Beta
၁.၇၁
Shares outstanding
၁၈.၇၃ ကုဋေ
No. of employees
၁၁၂
News stories
From web sources and news partners
Business Insider
·
ပြီးခဲ့သည့် ၃၅ မိနစ်
A veteran strategist sees a split in the stock market leading to a 15% drop in the S&P 500
Benzinga
·
ပြီးခဲ့သည့် ၅၂ မိနစ်
Stock Market Today: Dow Jones, S&P 500 Futures Trade Mixed as Scott Bessent Presses Nvidia Over China Chi
Investing.com
·
ပြီးခဲ့သည့် ၂ နာရီ
Morgan Stanley raises S&P 500 target on earnings growth, lower oil and AI adoption
Billionaires.Africa
·
ပြီးခဲ့သည့် ၁ နာရီ
American billionaire Elon Musk's SpaceX eyes S&P 500 entry through Tesla merger
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc